Literature DB >> 10540022

Visualization of defective mitochondrial function in skeletal muscle fibers of patients with sporadic amyotrophic lateral sclerosis.

S Vielhaber1, K Winkler, E Kirches, D Kunz, M Büchner, H Feistner, C E Elger, A C Ludolph, M W Riepe, W S Kunz.   

Abstract

The mitochondrial function in skeletal muscle was investigated in skeletal muscle biopsies of 26 patients with sporadic amyotrophic lateral sclerosis (ALS) and compared with investigations of 28 age-matched control muscle samples and biopsies of 6 patients with spinal muscular atrophy (SMA) and two patients with Tay-Sachs disease. In comparison to the control, SMA and Tay-Sachs biopsies, we observed in the ALS samples a significant about two-fold lower activity of complex I of mitochondrial respiratory chain. To visualise the distribution of the mitochondrial defect in skeletal muscle fibers we applied confocal laser-scanning microscopy and video fluorescence microscopy of NAD(P)H and fluorescent flavoproteins. The redox change of mitochondrial NAD(P)H and flavoproteins on addition of mitochondrial substrates, ADP, or cyanide were determined by measurement of fluorescence intensities with dual-photon UV-excitation and single-photon blue excitation. In skeletal muscle fibers of ALS patients with abnormalities of mitochondrial DNA (multiple deletions, n=1, or lower mtDNA levels, n=14) we observed a heterogeneous distribution of the mitochondrial defects among individual fibers and even within single fibers. In some patients (n=3) a mitochondrial defect was also detectable in cultivated skin fibroblasts. These findings support the viewpoint that the observed impairment of mitochondrial function in muscle of certain ALS patients is caused by an intrinsic mitochondrial defect which may be of pathophysiological significance in the etiology of this neurodegenerative disease.

Entities:  

Mesh:

Year:  1999        PMID: 10540022     DOI: 10.1016/s0022-510x(99)00236-1

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  34 in total

1.  Increased axonal mitochondrial mobility does not slow amyotrophic lateral sclerosis (ALS)-like disease in mutant SOD1 mice.

Authors:  Yi-Bing Zhu; Zu-Hang Sheng
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

Review 2.  Olesoxime, a cholesterol-like neuroprotectant for the potential treatment of amyotrophic lateral sclerosis.

Authors:  Lee J Martin
Journal:  IDrugs       Date:  2010-08

3.  Quantity and activation of myofiber-associated satellite cells in a mouse model of amyotrophic lateral sclerosis.

Authors:  Raquel Manzano; Janne M Toivonen; Ana Cristina Calvo; Sara Oliván; Pilar Zaragoza; Maria Jesús Muñoz; Didier Montarras; Rosario Osta
Journal:  Stem Cell Rev Rep       Date:  2012-03       Impact factor: 5.739

4.  Amyotrophic Lateral Sclerosis Associated with Statin Use: A Disproportionality Analysis of the FDA's Adverse Event Reporting System.

Authors:  Beatrice A Golomb; Abril Verden; Alexis K Messner; Hayley J Koslik; Keith B Hoffman
Journal:  Drug Saf       Date:  2018-04       Impact factor: 5.606

Review 5.  Aberrant regulation of DNA methylation in amyotrophic lateral sclerosis: a new target of disease mechanisms.

Authors:  Lee J Martin; Margaret Wong
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

6.  Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice.

Authors:  Margaret Wong; Lee J Martin
Journal:  Hum Mol Genet       Date:  2010-03-10       Impact factor: 6.150

Review 7.  TRPM7 and TRPM2-Candidate susceptibility genes for Western Pacific ALS and PD?

Authors:  Meredith C Hermosura; Ralph M Garruto
Journal:  Biochim Biophys Acta       Date:  2007-02-24

Review 8.  The mitochondrial permeability transition pore: a molecular target for amyotrophic lateral sclerosis therapy.

Authors:  Lee J Martin
Journal:  Biochim Biophys Acta       Date:  2009-08-03

Review 9.  Dysregulated mitochondrial Ca2+ and ROS signaling in skeletal muscle of ALS mouse model.

Authors:  Jingsong Zhou; Ang Li; Xuejun Li; Jianxun Yi
Journal:  Arch Biochem Biophys       Date:  2019-01-22       Impact factor: 4.013

10.  Cerebrospinal Fluid from Sporadic Amyotrophic Lateral Sclerosis Patients Induces Mitochondrial and Lysosomal Dysfunction.

Authors:  Aparna Sharma; Anu Mary Varghese; Kalyan Vijaylakshmi; Rajendrarao Sumitha; V K Prasanna; S Shruthi; B K Chandrasekhar Sagar; Keshava K Datta; Harsha Gowda; Atchayaram Nalini; Phalguni Anand Alladi; Rita Christopher; Talakad N Sathyaprabha; Trichur R Raju; M M Srinivas Bharath
Journal:  Neurochem Res       Date:  2015-12-08       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.